The debate continues over the potential of measurable residual disease to transform research and clinical care in hematology.

London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...

India also impacted by Shigellosis, a severe form of bacterial diarrhoea that disproportionately affects children under five ...

England’s NHS has launched a groundbreaking “Trojan Horse” therapy for the treatment of myeloma, offering hope for thousands ...

Bengaluru: In a BSE filing, Syngene International has informed that the company's facility at Semicon Park, Bengaluru has ...